Belluscura PLC (GB:BELL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Belluscura PLC, a UK-based medical device company, has announced the departure of Jonathan Satchell from his position as Non-executive Director effective from 11 July 2024. Satchell, who joined the Board in February 2024 following the acquisition of TMT Acquisition plc, has been praised by Chairman Adam Reynolds for his valuable contributions. Belluscura is known for its focus on developing lightweight and portable oxygen enrichment technology.
For further insights into GB:BELL stock, check out TipRanks’ Stock Analysis page.